Anteris Technologies Global Financial Results
Anteris Technologies Global Corp. reported its financial results for the third quarter ended September 30, 2026, filing its Form 10-Q with the SEC and providing supplementary disclosures for the Australian Securities Exchange (ASX). The company highlighted its ongoing development of the DurAVR THV biomimetic heart valve and disclosed $576,000 in payments to related parties, including executive salaries and director fees.
- Term
- Q3 2026